FDS
GSK icon

Freedom Day Solutions’s GSK GSK Stock Holding History

Freedom Day Solutions’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,252
Closed -$305K – 80
2018
Q1 		$305K Sell
6,252
-1,060
-14% -$49.4K 0.27% 66
2017
Q4 		$324K Buy
+7,312
New +$338K 0.27% 66

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Freedom Day Solutions's GSK Position: Q2 2018 in Review

Freedom Day Solutions sold out of GSK (GSK) in Q2 2018, closing a stake of 6,252 shares — an estimated $305K sold.

Freedom Day Solutions first reported a position in GSK in Q4 2017 and held it in 2 quarters. The position peaked at $324K in Q4 2017. 787 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

  • Freedom Day Solutions reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
  • Freedom Day Solutions sold 6,252 GSK shares in Q2 2018, an estimated $305K.
  • Freedom Day Solutions first reported a position in GSK in Q4 2017 and held it in 2 quarters.
  • Freedom Day Solutions's GSK position peaked at $324K in Q4 2017.
  • 787 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on Freedom Day Solutions's 13F filing for Q2 2018, filed 12 Jul 2018.